Brian Matthew Shuch

Title(s)Professor, Urology
SchoolMedicine
vCardDownload vCard

    Collapse Overview 
    Collapse Overview
    Dr. Brian Shuch formerly held the Henry Alvin and Carrie L. Meinhardt Chair for Kidney Cancer Research (9/1/2018 - 8/31/2023).

    Collapse Research 
    Collapse Research Activities and Funding
    Genomic Heterogeneity and the Small Renal Mass
    NIH K08CA207845Sep 1, 2016 - Aug 31, 2021
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. The impact of the new WHO Classification of renal cell carcinoma on the diagnosis of hereditary leiomyomatosis and renal cell carcinoma. Nephrol Dial Transplant. 2025 Feb 20. Degenhardt J, Tolkach Y, Amin MB, Mosiello G, Baydar DE, Gall EC, DiCola J, Elhag D, Frezza C, Halbritter J, Guillermo IB, Jewett MAS, Lattouf JB, Lovitt G, Lundgren PO, Maher ER, Mulders P, Shuch B, Hartmann A, Müller RU, HLRCC Alliance in collaboration with the ERA Working Group “Genes&Kidney”, the European Reference Ne. PMID: 39979023.
      View in: PubMed   Mentions:    Fields:    
    2. Clinical and genetic characteristics in two cases of Birt-Hogg-Dubé syndrome associated with papillary renal cell carcinoma and rare Folliculin (FLCN) variants. Cancer Genet. 2025 Jan 31; 292-293:65-68. Evans MG, Thomas LW, Nakasaki M, Charifa A, Sisk A, Liu S, Kuklinski LF, Shuch B, Quintero-Rivera F. PMID: 39893707.
      View in: PubMed   Mentions:    Fields:    
    3. 'BJUI Clinical Dilemma': the incidental small renal mass in a solitary kidney. BJU Int. 2025 Mar; 135(3):371-379. Gao B, Kanabur P, Campi R, Tran M, Landman J, Pedrosa I, Challacombe B, Wah TM, Siva S, Jewett M, Stewart GD, Shuch B, Clayman R. PMID: 39761985; PMCID: PMC11842889.
      View in: PubMed   Mentions:    Fields:    
    4. Impact of postprogression therapies on overall survival: Recommendations from the 2023 kidney cancer association think tank meeting. Urol Oncol. 2024 Nov 04. Berg SA, La Rosa S, Zhang T, Pierorazio PM, Albiges L, Beckermann KE, Campbell MT, Carlo MI, Coleman K, George DJ, Geynisman DM, Johnson R, Jonasch E, Maranchie JK, McGregor BA, Shapiro DD, Singer EA, Shuch BM, Stadler WM, Tannir NM, Zakharia Y, Vaishampayan UN, Thall PF, Msaouel P. PMID: 39500687.
      View in: PubMed   Mentions:    Fields:    
    5. Novel Radiopharmaceuticals and Future of Theranostics in Genitourinary Cancers. Eur Urol. 2025 Feb; 87(2):125-139. Sollini M, Calais J, Chiti A, Emmett L, Fanti S, Fendler W, Herrmann K, Hope TA, Sartor O, Shuch B, Tagawa S, Hofman MS. PMID: 39428326.
      View in: PubMed   Mentions:    Fields:    
    6. Pediatric patients with von Hippel-Lindau and hemangioblastomas treated successfully with belzutifan. Pediatr Blood Cancer. 2025 Jan; 72(1):e31371. Duan E, Robinson M, Davis C, Pruthi S, Shin C, Lewis M, Martinez-Agosto JA, Gorin MB, Shuch BM, Friedman DL, Chang VY. PMID: 39415342.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    7. NAPRT Silencing in FH-Deficient Renal Cell Carcinoma Confers Therapeutic Vulnerabilities via NAD+ Depletion. Mol Cancer Res. 2024 10 02; 22(10):973-988. Noronha KJ, Lucas KN, Paradkar S, Edmonds J, Friedman S, Murray MA, Liu S, Sajed DP, Sachs C, Spurrier J, Raponi M, Liang J, Zeng H, Sundaram RK, Shuch B, Vasquez JC, Bindra RS. PMID: 38949523; PMCID: PMC11445649.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    8. Adjuvant Nivolumab for Localized Renal Cell Carcinoma at High Risk of Recurrence After Nephrectomy: Part B of the Randomized, Placebo-Controlled, Phase III CheckMate 914 Trial. J Clin Oncol. 2025 Jan 10; 43(2):189-200. Motzer RJ, Bex A, Russo P, Tomita Y, Cutuli HJ, Rojas C, Gross-Goupil M, Schinzari G, Melichar B, Barthélémy P, Ruiz Garcia A, Sosman J, Grimm MO, Goh JC, Suarez C, Kollmannsberger CK, Nair SG, Shuch BM, Huang J, Simsek B, Spiridigliozzi J, Lee CW, van Kooten Losio M, Grünwald V. PMID: 39303200; PMCID: PMC11709003.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    9. Final Overall Survival Analysis of S1500: A Randomized, Phase II Study Comparing Sunitinib With Cabozantinib, Crizotinib, and Savolitinib in Advanced Papillary Renal Cell Carcinoma. J Clin Oncol. 2024 Nov 20; 42(33):3911-3916. Barata P, Tangen C, Plets M, Thompson IM, Narayan V, George DJ, Heng DYC, Shuch B, Stein M, Gulati S, Tretiakova M, Tripathi A, Bjarnason GA, Humphrey P, Adeniran A, Vaishampayan U, Alva A, Zhang T, Cole S, Lara PN, Lerner SP, Balzer-Haas N, Pal SK. PMID: 39255440; PMCID: PMC11575905.
      View in: PubMed   Mentions: 1     Fields:    Translation:CTClinical Trials
    10. [89Zr]Zr-girentuximab for PET-CT imaging of clear-cell renal cell carcinoma: a prospective, open-label, multicentre, phase 3 trial. Lancet Oncol. 2024 Oct; 25(10):1277-1287. Shuch B, Pantuck AJ, Bernhard JC, Morris MA, Master V, Scott AM, van Praet C, Bailly C, Önal B, Aksoy T, Merkx R, Schuster DM, Lee ST, Pandit-Taskar N, Fan AC, Allman P, Schmidt K, Tauchmanova L, Wheatcroft M, Behrenbruch C, Hayward CRW, Mulders P. PMID: 39270701.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    11. Adjuvant Everolimus in Non-Clear Cell Renal Cell Carcinoma: A Secondary Analysis of a Randomized Clinical Trial. JAMA Netw Open. 2024 Aug 01; 7(8):e2425288. Gulati S, Tangen C, Ryan CW, Vaishampayan UN, Shuch BM, Barata PC, Pruthi DK, Bergerot CD, Tripathi A, Lerner SP, Thompson IM, Lara PN, Pal SK. PMID: 39106067; PMCID: PMC11304111.
      View in: PubMed   Mentions:    Fields:    Translation:CTClinical Trials
    12. Pathological concordance rate and outcomes by subtype in advanced papillary renal cell carcinoma. BJU Int. 2024 Oct; 134(4):596-601. Tripathi A, Tangen CM, Plets M, Li X, Tretiakova M, Humphrey PA, Adeniran A, Barata PC, Gulati S, Bergerot CD, Pruthi DK, Thompson IM, Lara PN, Lerner SP, Pal SK, Shuch BM. PMID: 39014969.
      View in: PubMed   Mentions:    Fields:    
    13. Stage IA papillary and chromophobe renal cell carcinoma: effectiveness of cryoablation and partial nephrectomy. Insights Imaging. 2024 Jul 06; 15(1):171. Uhlig A, Uhlig J, Shuch B, Kim HS. PMID: 38971873; PMCID: PMC11227485.
      View in: PubMed   Mentions:
    14. Perioperative nivolumab versus observation in patients with renal cell carcinoma undergoing nephrectomy (PROSPER ECOG-ACRIN EA8143): an open-label, randomised, phase 3 study. Lancet Oncol. 2024 Aug; 25(8):1038-1052. Allaf ME, Kim SE, Master V, McDermott DF, Harshman LC, Cole SM, Drake CG, Signoretti S, Akgul M, Baniak N, Li-Ning E, Palmer MB, Emamekhoo H, Adra N, Kaimakliotis H, Ged Y, Pierorazio PM, Abel EJ, Bilen MA, Ogan K, Moon HH, Ramaswamy KA, Singer EA, Mayer TM, Lohrey J, Margulis V, Gills J, Delacroix SE, Waples MJ, James AC, Wang P, Choueiri T, Michaelson MD, Kapoor A, Heng DY, Shuch B, Leibovich BC, Lara PN, Manola J, Maskens D, Battle D, Uzzo R, Bratslavsky G, Haas NB, Carducci MA. PMID: 38942046; PMCID: PMC11323681.
      View in: PubMed   Mentions: 10     Fields:    Translation:CTClinical Trials
    15. Adjuvant Everolimus in Patients with Completely Resected, Very High-risk Renal Cell Carcinoma of Clear Cell Histology: Results from the Phase 3 Placebo-controlled SWOG S0931 (EVEREST) Trial. Eur Urol. 2024 Sep; 86(3):258-264. Lara PN, Tangen C, Heath EI, Gulati S, Stein MN, Meng M, Alva AS, Pal SK, Puzanov I, Clark JI, Choueiri TK, Agarwal N, Uzzo R, Haas NB, Synold TW, Plets M, Vaishampayan UN, Shuch BM, Lerner S, Thompson IM, Ryan CW. PMID: 38811313.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    16. Utilization of a Third-party Partnership in Tele-genetic Risk Assessment Program in Genitourinary Oncology. Urology. 2024 Sep; 191:95-100. Lin L, Lu E, Yurasits J, Mercado J, Myers M, Holden S, Shuch B. PMID: 38795832.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    17. Sarcomatoid and Rhabdoid Renal Cell Carcinoma: Clinical, Pathologic, and Molecular Genetic Features. Am J Surg Pathol. 2024 Jul 01; 48(7):e65-e88. Adeniran AJ, Shuch B, Humphrey PA. PMID: 38736105.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    18. The effect of a fermented soy beverage among patients with localized prostate cancer prior to radical prostatectomy. BMC Urol. 2024 May 03; 24(1):102. Lokeshwar SD, Ali A, Weiss TR, Reynolds J, Shuch BM, Ferencz T, Kyriakides TC, Mehal WZ, Brito J, Renzulli J, Leapman MS. PMID: 38702664; PMCID: PMC11067086.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    19. Multi-ancestry genome-wide association study of kidney cancer identifies 63 susceptibility regions. Nat Genet. 2024 May; 56(5):809-818. Purdue MP, Dutta D, Machiela MJ, Gorman BR, Winter T, Okuhara D, Cleland S, Ferreiro-Iglesias A, Scheet P, Liu A, Wu C, Antwi SO, Larkin J, Zequi SC, Sun M, Hikino K, Hajiran A, Lawson KA, Cárcano F, Blanchet O, Shuch B, Nepple KG, Margue G, Sundi D, Diver WR, Folgueira MAAK, van Bokhoven A, Neffa F, Brown KM, Hofmann JN, Rhee J, Yeager M, Cole NR, Hicks BD, Manning MR, Hutchinson AA, Rothman N, Huang WY, Linehan WM, Lori A, Ferragu M, Zidane-Marinnes M, Serrano SV, Magnabosco WJ, BioBank Japan Project, Vilas A, Decia R, Carusso F, Graham LS, Anderson K, Bilen MA, Arciero C, Pellegrin I, Ricard S, FinnGen, Scelo G, Banks RE, Vasudev NS, Soomro N, Stewart GD, Adeyoju A, Bromage S, Hrouda D, Gibbons N, Patel P, Sullivan M, Protheroe A, Nugent FI, Fournier MJ, Zhang X, Martin LJ, Komisarenko M, Eisen T, Cunningham SA, Connolly DC, Uzzo RG, Zaridze D, Mukeria A, Holcatova I, Hornakova A, Foretova L, Janout V, Mates D, Jinga V, Rascu S, Mijuskovic M, Savic S, Milosavljevic S, Gaborieau V, Abedi-Ardekani B, McKay J, Johansson M, Phouthavongsy L, Hayman L, Li J, Lungu I, Bezerra SM, Souza AG, Sares CTG, Reis RB, Gallucci FP, Cordeiro MD, Pomerantz M, Lee GM, Freedman ML, Jeong A, Greenberg SE, Sanchez A, Thompson RH, Sharma V, Thiel DD, Ball CT, Abreu D, Lam ET, Nahas WC, Master VA, Patel AV, Bernhard JC, Freedman ND, Bigot P, Reis RM, Colli LM, Finelli A, Manley BJ, Terao C, Choueiri TK, Carraro DM, Houlston R, Eckel-Passow JE, Abbosh PH, Ganna A, Brennan P, Gu J, Chanock SJ. PMID: 38671320.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    20. The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2024 Apr 23; 43(4):113063. Ricketts CJ, De Cubas AA, Fan H, Smith CC, Lang M, Reznik E, Bowlby R, Gibb EA, Akbani R, Beroukhim R, Bottaro DP, Choueiri TK, Gibbs RA, Godwin AK, Haake S, Hakimi AA, Henske EP, Hsieh JJ, Ho TH, Kanchi RS, Krishnan B, Kwiatkowski DJ, Liu W, Merino MJ, Mills GB, Myers J, Nickerson ML, Reuter VE, Schmidt LS, Shelley CS, Shen H, Shuch B, Signoretti S, Srinivasan R, Tamboli P, Thomas G, Vincent BG, Vocke CD, Wheeler DA, Yang L, Kim WY, Robertson AG, Cancer Genome Atlas Research Network, Spellman PT, Rathmell WK, Linehan WM. PMID: 38578829.
      View in: PubMed   Mentions: 1     Fields:    
    21. Gain of Chromosome 5q Predicts a Favorable Prognosis in Localized Renal Cell Carcinoma. Cancer Invest. 2024 Jan; 42(1):97-103. Lebacle C, Pooli A, Shuch B, Rao N, Chamie K, Kroeger N, Faiena I, Liu S, Wood EL, Belldegrun A, Drakaki A, Pantuck AJ. PMID: 38314786.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    22. NCCN Guidelines® Insights: Kidney Cancer, Version 2.2024. J Natl Compr Canc Netw. 2024 02; 22(1):4-16. Motzer RJ, Jonasch E, Agarwal N, Alva A, Bagshaw H, Baine M, Beckermann K, Carlo MI, Choueiri TK, Costello BA, Derweesh IH, Desai A, Ged Y, George S, Gore JL, Gunn A, Haas N, Johnson M, Kapur P, King J, Kyriakopoulos C, Lam ET, Lara PN, Lau C, Lewis B, Madoff DC, Manley B, Michaelson MD, Mortazavi A, Ponsky L, Ramalingam S, Shuch B, Smith ZL, Sosman J, Sweis R, Zibelman M, Schonfeld R, Stein M, Gurski LA. PMID: 38394781.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    23. CD70 is Consistently Expressed in Primary and Metastatic Clear Cell Renal Cell Carcinoma. Clin Genitourin Cancer. 2024 04; 22(2):347-353. Huang RR, Chen Z, Kroeger N, Pantuck A, Said J, Kluger HM, Shuch B, Ye H. PMID: 38195301.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    24. Social determinants as predictors of resection and long-term mortality in Black patients with non-small cell lung cancer. Surgery. 2024 02; 175(2):505-512. Coaston TN, Sakowitz S, Chervu NL, Branche C, Shuch BM, Benharash P, Revels S. PMID: 37949695.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    25. Persistent racial disparities in refusal of resection in non-small cell lung cancer patients at high-volume and Black-serving institutions. Surgery. 2023 12; 174(6):1428-1435. Coaston TN, Sakowitz S, Chervu NL, Branche C, Shuch BM, Benharash P, Revels S. PMID: 37821266.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    26. FH Variant Pathogenicity Promotes Purine Salvage Pathway Dependence in Kidney Cancer. Cancer Discov. 2023 09 06; 13(9):2072-2089. Wilde BR, Chakraborty N, Matulionis N, Hernandez S, Ueno D, Gee ME, Esplin ED, Ouyang K, Nykamp K, Shuch B, Christofk HR. PMID: 37255402; PMCID: PMC10527600.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    27. Summary of Research: Adjuvant Nivolumab Plus Ipilimumab Versus Placebo for Localized Renal Cell Carcinoma After Nephrectomy (CheckMate 914): A Double-Blind, Randomized, Phase 3 Trial. Target Oncol. 2023 09; 18(5):639-641. Motzer RJ, Russo P, Grünwald V, Tomita Y, Zurawski B, Parikh O, Buti S, Barthélémy P, Goh JC, Ye D, Lingua A, Lattouf JB, Albigès L, George S, Shuch B, Sosman J, Staehler M, Vázquez Estévez S, Simsek B, Spiridigliozzi J, Chudnovsky A, Bex A. PMID: 37659025; PMCID: PMC10517884.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    28. Adjuvant everolimus after surgery for renal cell carcinoma (EVEREST): a double-blind, placebo-controlled, randomised, phase 3 trial. Lancet. 2023 09 23; 402(10407):1043-1051. Ryan CW, Tangen CM, Heath EI, Stein MN, Meng MV, Alva AS, Pal SK, Puzanov I, Clark JI, Choueiri TK, Agarwal N, Uzzo RG, Haas NB, Synold TW, Plets M, Vaishampayan UN, Shuch BM, Thompson IM, Lara PN. PMID: 37524096; PMCID: PMC10622111.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCTClinical Trials
    29. [68Ga]Ga-FAPI-46 PET for Visualization of Postinfarction Renal Fibrosis. J Nucl Med. 2023 10; 64(10):1660-1661. Unterrainer LM, Sisk AE, Czernin J, Shuch BM, Calais J, Hotta M. PMID: 37321822.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    30. Comparative analyses define differences between BHD-associated renal tumour and sporadic chromophobe renal cell carcinoma. EBioMedicine. 2023 Jun; 92:104596. Jikuya R, Johnson TA, Maejima K, An J, Ju YS, Lee H, Ha K, Song W, Kim Y, Okawa Y, Sasagawa S, Kanazashi Y, Fujita M, Imoto S, Mitome T, Ohtake S, Noguchi G, Kawaura S, Iribe Y, Aomori K, Tatenuma T, Komeya M, Ito H, Ito Y, Muraoka K, Furuya M, Kato I, Fujii S, Hamanoue H, Tamura T, Baba M, Suda T, Kodama T, Makiyama K, Yao M, Shuch BM, Ricketts CJ, Schmidt LS, Linehan WM, Nakagawa H, Hasumi H. PMID: 37182269; PMCID: PMC10200853.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    31. Contemporary care patterns in the management of small renal masses. Am J Manag Care. 2023 05 01; 29(5):e143-e148. Mendhiratta N, Hong BD, Johnson D, Sharma V, Baecker AS, Osuji TA, Shuch B, Gould ME. PMID: 37229788.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    32. Disparate Utilization of Breast Conservation Therapy in the Surgical Management of Early-Stage Breast Cancer. Clin Breast Cancer. 2023 07; 23(5):561-566. Chervu N, Darbinian K, Sakowitz S, Verma A, Bakhtiyar SS, Shuch BM, Benharash P, Thompson C. PMID: 37183095.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    33. Current Landscape of Genomic Biomarkers in Clear Cell Renal Cell Carcinoma. Eur Urol. 2023 08; 84(2):166-175. Cotta BH, Choueiri TK, Cieslik M, Ghatalia P, Mehra R, Morgan TM, Palapattu GS, Shuch B, Vaishampayan U, Van Allen E, Ari Hakimi A, Salami SS. PMID: 37085424; PMCID: PMC11175840.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    34. Fumarate Hydratase Variants and Their Association With Paraganglioma/Pheochromocytoma. Urology. 2023 06; 176:106-114. Zavoshi S, Lu E, Boutros PC, Zhang L, Harari A, Hatchell KE, Nielsen SM, Esplin ED, Ouyang K, Nykamp K, Wilde B, Christofk H, Shuch B. PMID: 36773955.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    35. Adjuvant nivolumab plus ipilimumab versus placebo for localised renal cell carcinoma after nephrectomy (CheckMate 914): a double-blind, randomised, phase 3 trial. Lancet. 2023 03 11; 401(10379):821-832. Motzer RJ, Russo P, Grünwald V, Tomita Y, Zurawski B, Parikh O, Buti S, Barthélémy P, Goh JC, Ye D, Lingua A, Lattouf JB, Albigès L, George S, Shuch B, Sosman J, Staehler M, Vázquez Estévez S, Simsek B, Spiridigliozzi J, Chudnovsky A, Bex A. PMID: 36774933; PMCID: PMC10259621.
      View in: PubMed   Mentions: 50     Fields:    Translation:HumansCTClinical Trials
    36. CD70-Targeted Micelles Enhance HIF2α siRNA Delivery and Inhibit Oncogenic Functions in Patient-Derived Clear Cell Renal Carcinoma Cells. Molecules. 2022 Dec 02; 27(23). Trac N, Oh HS, Jones LI, Caliliw R, Ohtake S, Shuch B, Chung EJ. PMID: 36500549; PMCID: PMC9738223.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    37. Perioperative Nephrectomy Outcomes for Patients with Liver Disease: Implications for Liver Transplant Candidates. Urology. 2023 03; 173:127-133. Muraki P, Lee C, Patel N, Arevalo A, Ohtake S, Mendhiratta N, Chamie K, Agopian V, Benharash P, Shuch B. PMID: 36403677.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    38. Transcriptomic recurrence score improves recurrence prediction for surgically treated patients with intermediate-risk clear cell kidney cancer. Cancer Med. 2023 03; 12(5):6437-6444. Patel N, Hakansson A, Ohtake S, Muraki P, Proudfout JA, Liu Y, Webber L, Ibarra A, Liu VYT, Davicioni E, Chamie K, Pantuck A, Shuch B. PMID: 36397716; PMCID: PMC10028022.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    39. Cost-effectiveness of minimally invasive partial nephrectomy and percutaneous cryoablation for cT1a renal cell carcinoma. Eur Radiol. 2023 Mar; 33(3):1801-1811. Wu X, Uhlig J, Shuch BM, Uhlig A, Kim HS. PMID: 36329348.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    40. 2022 WUOF/SIU International Consultation on Urological Diseases: Active Surveillance for Small Renal Masses. Soc Int Urol J. 2022 Nov; 3(6):424-436. Kauffman EC, Ball MW, Barod R, Capitanio U, Finelli A, Mir MC, Shuch B, Smaldone MC, Tran MGB, Pierorazio PM. PMID: 38836217; PMCID: PMC11149394.
      View in: PubMed   Mentions:
    41. Understanding the Impact of Belzutifan on Treatment Strategies for Patients with VHL. J Kidney Cancer VHL. 2022; 9(3):41-46. Arevalo A, Patel N, Muraki P, Ohtake S, Bratslavsky G, Clark C, Mann J, Iliopoulos O, Jonasch E, Srinivasan R, Shuch B. PMID: 36310638; PMCID: PMC9551368.
      View in: PubMed   Mentions:
    42. Targeting Krebs-cycle-deficient renal cell carcinoma with Poly ADP-ribose polymerase inhibitors and low-dose alkylating chemotherapy. Oncotarget. 2022; 13:1054-1067. Ueno D, Vasquez JC, Sule A, Liang J, van Doorn J, Sundaram R, Friedman S, Caliliw R, Ohtake S, Bao X, Li J, Ye H, Boyd K, Huang RR, Dodson J, Boutros P, Bindra RS, Shuch B. PMID: 36128328; PMCID: PMC9477221.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimalsCells
    43. Epidemiology of Renal Cell Carcinoma: 2022 Update. Eur Urol. 2022 11; 82(5):529-542. Bukavina L, Bensalah K, Bray F, Carlo M, Challacombe B, Karam JA, Kassouf W, Mitchell T, Montironi R, O'Brien T, Panebianco V, Scelo G, Shuch B, van Poppel H, Blosser CD, Psutka SP. PMID: 36100483.
      View in: PubMed   Mentions: 169     Fields:    Translation:Humans
    44. Single-cell transcriptomes underscore genetically distinct tumor characteristics and microenvironment for hereditary kidney cancers. iScience. 2022 Jun 17; 25(6):104463. Jikuya R, Murakami K, Nishiyama A, Kato I, Furuya M, Nakabayashi J, Ramilowski JA, Hamanoue H, Maejima K, Fujita M, Mitome T, Ohtake S, Noguchi G, Kawaura S, Odaka H, Kawahara T, Komeya M, Shinoki R, Ueno D, Ito H, Ito Y, Muraoka K, Hayashi N, Kondo K, Nakaigawa N, Hatano K, Baba M, Suda T, Kodama T, Fujii S, Makiyama K, Yao M, Shuch BM, Schmidt LS, Linehan WM, Nakagawa H, Tamura T, Hasumi H. PMID: 35874919; PMCID: PMC9301876.
      View in: PubMed   Mentions: 4  
    45. Kidney Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2022 01; 20(1):71-90. Motzer RJ, Jonasch E, Agarwal N, Alva A, Baine M, Beckermann K, Carlo MI, Choueiri TK, Costello BA, Derweesh IH, Desai A, Ged Y, George S, Gore JL, Haas N, Hancock SL, Kapur P, Kyriakopoulos C, Lam ET, Lara PN, Lau C, Lewis B, Madoff DC, Manley B, Michaelson MD, Mortazavi A, Nandagopal L, Plimack ER, Ponsky L, Ramalingam S, Shuch B, Smith ZL, Sosman J, Dwyer MA, Gurski LA, Motter A. PMID: 34991070; PMCID: PMC10191161.
      View in: PubMed   Mentions: 187     Fields:    Translation:Humans
    46. Fumarate hydratase variant prevalence and manifestations among individuals receiving germline testing. Cancer. 2022 02 15; 128(4):675-684. Lu E, Hatchell KE, Nielsen SM, Esplin ED, Ouyang K, Nykamp K, Zavoshi S, Li S, Zhang L, Wilde BR, Christofk HR, Boutros PC, Shuch B. PMID: 34724198; PMCID: PMC9170268.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    47. Decisional Regret and Financial Toxicity among Patients with Benign Renal Masses. Urol Pract. 2022 01; 9(1):32-39. Mendhiratta N, Sharma V, Wu J, Valdez T, Patel N, Gottsleben D, Battle D, Saigal C, Shuch B. PMID: 37145562.
      View in: PubMed   Mentions:    Fields:    
    48. Adverse Histopathologic Characteristics in Small Papillary Renal Cell Carcinomas Have Minimal Impact on Prognosis. Am J Clin Pathol. 2021 Sep 08; 156(4):550-558. Yang C, Shuch B, Kluger HM, Serrano M, Kibel AS, Humphrey PA, Adeniran AJ. PMID: 34424955.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    49. Genetic risk assessment for hereditary renal cell carcinoma: Clinical consensus statement. Cancer. 2021 Nov 01; 127(21):3957-3966. Bratslavsky G, Mendhiratta N, Daneshvar M, Brugarolas J, Ball MW, Metwalli A, Nathanson KL, Pierorazio PM, Boris RS, Singer EA, Carlo MI, Daly MB, Henske EP, Hyatt C, Middleton L, Morris G, Jeong A, Narayan V, Rathmell WK, Vaishampayan U, Lee BH, Battle D, Hall MJ, Hafez K, Jewett MAS, Karamboulas C, Pal SK, Hakimi AA, Kutikov A, Iliopoulos O, Linehan WM, Jonasch E, Srinivasan R, Shuch B. PMID: 34343338; PMCID: PMC8711633.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    50. Role of Imaging in Renal Cell Carcinoma: A Multidisciplinary Perspective. Radiographics. 2021 Sep-Oct; 41(5):1387-1407. Abou Elkassem AM, Lo SS, Gunn AJ, Shuch BM, Dewitt-Foy ME, Abouassaly R, Vaidya SS, Clark JI, Louie AV, Siva S, Grosu AL, Smith AD. PMID: 34270355.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    51. Sequencing of Renal Mass Biopsy and Ablation: Results from the National Cancer Database. Urol Pract. 2021 Sep; 8(5):555-564. Uhlig A, Lenis A, Wang X, Shuch B. PMID: 37145397.
      View in: PubMed   Mentions: 1     Fields:    
    52. Papillary renal cell carcinoma: Review. Urol Oncol. 2021 06; 39(6):327-337. Mendhiratta N, Muraki P, Sisk AE, Shuch B. PMID: 34034966.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    53. Reply to Alexa R. Meyer, Steven P. Rowe, and Nirmish Singla's Letter to the Editor re: Patrick D. McGillivray, Daiki Ueno, Aydin Pooli, et al. Distinguishing Benign Renal Tumors with an Oncocytic Gene Expression (ONEX) Classifier. Eur Urol 2021;79:107-11. Integrating 99mTc-sestamibi and ONEX to Optimize Risk Stratification for Renal Masses. Eur Urol. 2021 07; 80(1):e22-e23. Shuch B, Raman S, Calais J. PMID: 33941405.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    54. 68Ga-FAPI-46 and 18F-FDG PET/CT in a patient with immune-related thyroiditis induced by immune checkpoint inhibitors. Eur J Nucl Med Mol Imaging. 2021 10; 48(11):3736-3737. Hotta M, Sonni I, Benz MR, Gafita A, Bahri S, Shuch BM, Yu R, Liu ST, Czernin J, Calais J. PMID: 33914106.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    55. HIF2 Inhibition for von-Hippel Lindau Associated Kidney Cancer: Will Urology Lead or Follow? Urol Oncol. 2021 05; 39(5):277-280. Shuch B. PMID: 34297683.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    56. A comparison of sunitinib with cabozantinib, crizotinib, and savolitinib for treatment of advanced papillary renal cell carcinoma: a randomised, open-label, phase 2 trial. Lancet. 2021 02 20; 397(10275):695-703. Pal SK, Tangen C, Thompson IM, Balzer-Haas N, George DJ, Heng DYC, Shuch B, Stein M, Tretiakova M, Humphrey P, Adeniran A, Narayan V, Bjarnason GA, Vaishampayan U, Alva A, Zhang T, Cole S, Plets M, Wright J, Lara PN. PMID: 33592176; PMCID: PMC8687736.
      View in: PubMed   Mentions: 90     Fields:    Translation:HumansCTClinical Trials
    57. Advances in the Characterization of Clear Cell Papillary Renal Cell Carcinoma: Identifying the Sheep in Wolf's Clothing. Eur Urol. 2021 04; 79(4):478-479. Filippou P, Shuch B, Psutka SP. PMID: 33579573.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    58. Telemedicine-Based Perioperative Management of Pheochromocytoma in a Patient With Von Hippel Lindau Disease: A Case Report. A A Pract. 2021 Jan 14; 15(1):e01378. Saksa D, Shuch B, Donahue T, Cusumano L, Yu R, Alapag C, Kamdar N. PMID: 33512909.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    59. Novel Liquid Biomarkers and Innovative Imaging for Kidney Cancer Diagnosis: What Can Be Implemented in Our Practice Today? A Systematic Review of the Literature. Eur Urol Oncol. 2021 02; 4(1):22-41. Campi R, Stewart GD, Staehler M, Dabestani S, Kuczyk MA, Shuch BM, Finelli A, Bex A, Ljungberg B, Capitanio U. PMID: 33408053.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    60. Radiomic Features and Machine Learning for the Discrimination of Renal Tumor Histological Subtypes: A Pragmatic Study Using Clinical-Routine Computed Tomography. Cancers (Basel). 2020 Oct 16; 12(10). Uhlig J, Leha A, Delonge LM, Haack AM, Shuch B, Kim HS, Bremmer F, Trojan L, Lotz J, Uhlig A. PMID: 33081400; PMCID: PMC7603020.
      View in: PubMed   Mentions: 17  
    61. Distinguishing Benign Renal Tumors with an Oncocytic Gene Expression (ONEX) Classifier. Eur Urol. 2021 01; 79(1):107-111. McGillivray PD, Ueno D, Pooli A, Mendhiratta N, Syed JS, Nguyen KA, Schulam PG, Humphrey PA, Adeniran AJ, Boutros PC, Shuch B. PMID: 32972793; PMCID: PMC8939926.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    62. Fear of Cancer Recurrence in Patients With Localized Renal Cell Carcinoma. JCO Oncol Pract. 2020 11; 16(11):e1264-e1271. Bergerot CD, Battle D, Philip EJ, Bergerot PG, Msaouel P, Smith A', Bamgboje AE, Shuch B, Derweesh IH, Jonasch E, Stern AP, Pal SK, Staehler M. PMID: 32955409.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    63. NCCN Guidelines Insights: Kidney Cancer, Version 1.2021. J Natl Compr Canc Netw. 2020 09; 18(9):1160-1170. Motzer RJ, Jonasch E, Boyle S, Carlo MI, Manley B, Agarwal N, Alva A, Beckermann K, Choueiri TK, Costello BA, Derweesh IH, Desai A, George S, Gore JL, Haas N, Hancock SL, Kyriakopoulos C, Lam ET, Lau C, Lewis B, Madoff DC, McCreery B, Michaelson MD, Mortazavi A, Nandagopal L, Pierorazio PM, Plimack ER, Ponsky L, Ramalingam S, Shuch B, Smith ZL, Somer B, Sosman J, Dwyer MA, Motter AD. PMID: 32886895; PMCID: PMC10191771.
      View in: PubMed   Mentions: 114     Fields:    Translation:Humans
    64. Analysis of guideline recommended use of renal mass biopsy and association with treatment. Can J Urol. 2020 08; 27(4):10285-10293. Michel J, Lenis AT, Lec PM, Golla V, Johnson DC, Gollapudi K, Blumberg J, Shuch BM, Chamie K. PMID: 32861253.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    65. Adjuvant Therapy for Localized High-Risk Renal Cell Carcinoma. Urol Clin North Am. 2020 Aug; 47(3):345-358. Wood E, Donin N, Shuch B. PMID: 32600536.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    66. The Association Between the Affordable Care Act and Insurance Status, Stage and Treatment in Patients with Testicular Cancer. Urol Pract. 2020 Jul; 7(4):252-258. Hsiang W, Han X, Jemal A, Nguyen KA, Shuch B, Park H, Yu JB, Gross CP, Davidoff AJ, Leapman MS. PMID: 34017908; PMCID: PMC8130174.
      View in: PubMed   Mentions: 1     Fields:    
    67. Reply by Authors. J Urol. 2020 09; 204(3):536-537. Geynisman DM, Kadow BT, Shuch BM, Boorjian SA, Matin SF, Rampersaud E, Milestone BN, Plimack ER, Zibelman MR, Kutikov A, Smaldone MC, Chen DY, Viterbo R, Joshi S, Greenberg RE, Malizzia L, McGowan T, Ross EA, Uzzo RG. PMID: 32574522.
      View in: PubMed   Mentions:    Fields:    
    68. The Role of Opioids and Their Receptors in Urological Malignancy: A Review. J Urol. 2020 Dec; 204(6):1150-1159. Lec PM, Lenis AT, Golla V, Brisbane W, Shuch B, Garraway IP, Reiter RE, Chamie K. PMID: 32516030.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    69. Oncometabolites suppress DNA repair by disrupting local chromatin signalling. Nature. 2020 06; 582(7813):586-591. Sulkowski PL, Oeck S, Dow J, Economos NG, Mirfakhraie L, Liu Y, Noronha K, Bao X, Li J, Shuch BM, King MC, Bindra RS, Glazer PM. PMID: 32494005; PMCID: PMC7319896.
      View in: PubMed   Mentions: 125     Fields:    Translation:HumansCells
    70. Ovarian BDNF promotes survival, migration, and attachment of tumor precursors originated from p53 mutant fallopian tube epithelial cells. Oncogenesis. 2020 May 29; 9(5):55. Kang M, Chong KY, Hartwich TMP, Bi F, Witham AK, Patrick D, Morrisson MJ, Cady SL, Cerchia AP, Kelk D, Liu Y, Nucci J, Madarikan O, Ueno D, Shuch BM, Yang-Hartwich Y. PMID: 32471985; PMCID: PMC7260207.
      View in: PubMed   Mentions: 8  
    71. Estimation of the carrier frequency of fumarate hydratase alterations and implications for kidney cancer risk in hereditary leiomyomatosis and renal cancer. Cancer. 2020 08 15; 126(16):3657-3666. Shuch B, Li S, Risch H, Bindra RS, McGillivray PD, Gerstein M. PMID: 32413184; PMCID: PMC10316675.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    72. High WHO/ISUP Grade and Unfavorable Architecture, Rather Than Typing of Papillary Renal Cell Carcinoma, May Be Associated With Worse Prognosis. Am J Surg Pathol. 2020 05; 44(5):582-593. Yang C, Shuch B, Kluger H, Humphrey PA, Adeniran AJ. PMID: 32101890.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    73. Sporadic Angiomyolipomas Growth Kinetics While on Everolimus: Results of a Phase II Trial. J Urol. 2020 Sep; 204(3):531-537. Geynisman DM, Kadow BT, Shuch BM, Boorjian SA, Matin SF, Rampersaud E, Milestone BN, Plimack ER, Zibelman MR, Kutikov A, Smaldone MC, Chen DY, Viterbo R, Joshi S, Greenberg RE, Malizzia L, McGowan T, Ross EA, Uzzo RG. PMID: 32250730; PMCID: PMC7695484.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    74. Transcriptomics in RCC. Urol Oncol. 2020 10; 38(10):742-754. Syed JS, Brito J, Pooli A, Boutros PC, Shuch B. PMID: 32222350.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    75. Understanding racial disparities in renal cell carcinoma incidence: estimates of population attributable risk in two US populations. Cancer Causes Control. 2020 Jan; 31(1):85-93. Callahan CL, Schwartz K, Corley DA, Ruterbusch JJ, Zhao WK, Shuch B, Graubard BI, Rothman N, Chow WH, Silverman DT, Purdue MP, Hofmann JN. PMID: 31782041; PMCID: PMC7717618.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    76. Genetic Testing in Kidney Cancer Patients: Who, When, and How? Eur Urol Focus. 2019 Nov; 5(6):973-976. Lui ST, Shuch B. PMID: 31594702.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansPHPublic Health
    77. Adverse Histopathologic Characteristics in Small Clear Cell Renal Cell Carcinomas Have Negative Impact on Prognosis: A Study of 631 Cases With Clinical Follow-up. Am J Surg Pathol. 2019 10; 43(10):1413-1420. Yang C, Shuch B, Serrano M, Kibel AS, Nawaf C, Vollmer R, Humphrey PA, Adeniran AJ. PMID: 31335354.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    78. Brain Metastasis From Renal-Cell Carcinoma: An Institutional Study. Clin Genitourin Cancer. 2019 12; 17(6):e1163-e1170. Suarez-Sarmiento A, Nguyen KA, Syed JS, Nolte A, Ghabili K, Cheng M, Liu S, Chiang V, Kluger H, Hurwitz M, Shuch B. PMID: 31519468.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    79. Quantitative Profiling of Oncometabolites in Frozen and Formalin-Fixed Paraffin-Embedded Tissue Specimens by Liquid Chromatography Coupled with Tandem Mass Spectrometry. Sci Rep. 2019 08 02; 9(1):11238. Bao X, Wu J, Shuch B, LoRusso P, Bindra RS, Li J. PMID: 31375752; PMCID: PMC6677826.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    80. Familial Kidney Cancer: Implications of New Syndromes and Molecular Insights. Eur Urol. 2019 12; 76(6):754-764. Carlo MI, Hakimi AA, Stewart GD, Bratslavsky G, Brugarolas J, Chen YB, Linehan WM, Maher ER, Merino MJ, Offit K, Reuter VE, Shuch B, Coleman JA. PMID: 31326218; PMCID: PMC7673107.
      View in: PubMed   Mentions: 50     Fields:    Translation:Humans
    81. Inherited kidney cancer syndromes. Curr Opin Urol. 2019 07; 29(4):334-343. Ball MW, Shuch BM. PMID: 31083011.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansPHPublic Health
    82. Development of a 2-dimensional atlas of the human kidney with imaging mass cytometry. JCI Insight. 2019 06 20; 4(12). Singh N, Avigan ZM, Kliegel JA, Shuch BM, Montgomery RR, Moeckel GW, Cantley LG. PMID: 31217358; PMCID: PMC6629112.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    83. Inhibition of Heat Shock Protein 90 suppresses TWIST1 Transcription. Mol Pharmacol. 2019 08; 96(2):168-179. Chong KY, Kang M, Garofalo F, Ueno D, Liang H, Cady S, Madarikan O, Pitruzzello N, Tsai CH, Hartwich TMP, Shuch BM, Yang-Hartwich Y. PMID: 31175180.
      View in: PubMed   Mentions: 14     Fields:    
    84. Considerations for the Next Clinical Trial Evaluating the Role of Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma. Eur Urol Focus. 2019 Nov; 5(6):927-929. Kim HL, Mayerson E, Lara PN, Messing E, Tangen C, Shuch BM, Vaishampayan U. PMID: 31103605; PMCID: PMC6858992.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    85. Harnessing the Genomic Landscape of the Small Renal Mass to Guide Clinical Management. Eur Urol Focus. 2019 11; 5(6):949-957. Silagy AW, Sanchez A, Manley BJ, Bensalah K, Bex A, Karam JA, Ljungberg B, Shuch B, Hakimi AA. PMID: 31040082; PMCID: PMC6815690.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    86. The future of perioperative therapy in advanced renal cell carcinoma: how can we PROSPER? Future Oncol. 2019 May; 15(15):1683-1695. Patel HD, Puligandla M, Shuch BM, Leibovich BC, Kapoor A, Master VA, Drake CG, Heng DY, Lara PN, Choueiri TK, Maskens D, Singer EA, Eggener SE, Svatek RS, Stadler WM, Cole S, Signoretti S, Gupta RT, Michaelson MD, McDermott DF, Cella D, Wagner LI, Haas NB, Carducci MA, Harshman LC, Allaf ME. PMID: 30968729; PMCID: PMC6595543.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCTClinical Trials
    87. Outcomes of upper tract urothelial cancer managed non-surgically. Can J Urol. 2019 04; 26(2):9699-9707. Syed JS, Nguyen KA, Suarez-Sariemento A, Leung C, Casilla-Lennon M, Raman JD, Shuch B. PMID: 31012833.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    88. Barriers to pre-treatment genomic characterization of the small renal mass. Oncotarget. 2019 Mar 01; 10(18):1667-1668. Syed JS, Lebacle C, Shuch B. PMID: 30899439; PMCID: PMC6422204.
      View in: PubMed   Mentions: 1     Fields:    
    89. Active Surveillance Versus Nephron-Sparing Surgery for a Bosniak IIF or III Renal Cyst: A Cost-Effectiveness Analysis. AJR Am J Roentgenol. 2019 04; 212(4):830-838. Smith AD, Carson JD, Sirous R, Sanyal R, Remer EM, Allen BC, Cox KL, Shuch B, Elkassem AA, Zhang X. PMID: 30779659.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    90. Glutamine and the Tumor Immune Microenvironment. Eur Urol. 2019 05; 75(5):764-765. Faiena I, Ueno D, Shuch B. PMID: 30711333.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    91. National trends and economic impact of surgical treatment for benign kidney tumors. Urol Oncol. 2019 03; 37(3):183.e9-183.e15. Nguyen KA, Brito J, Hsiang W, Nolte A, Syed JS, Suarez-Sarmiento A, Leapman MS, Shuch B. PMID: 30587401.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    92. Risk factors for metachronous bilateral renal cell carcinoma: A surveillance, epidemiology, and end results analysis. Cancer. 2019 01 15; 125(2):232-238. Syed JS, Nguyen KA, Holford TR, Hofmann JN, Shuch B. PMID: 30561791.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    93. Genetic Predisposition to Renal Cell Carcinoma: Implications for Counseling, Testing, Screening, and Management. J Clin Oncol. 2018 10 29; JCO2018792523. Shuch B, Zhang J. PMID: 30372385.
      View in: PubMed   Mentions: 17     Fields:    
    94. Pathologic Oxidation of PTPN12 Underlies ABL1 Phosphorylation in Hereditary Leiomyomatosis and Renal Cell Carcinoma. Cancer Res. 2018 12 01; 78(23):6539-6548. Xu Y, Taylor P, Andrade J, Ueberheide B, Shuch B, Glazer PM, Bindra RS, Moran MF, Linehan WM, Neel BG. PMID: 30297534; PMCID: PMC6279512.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    95. Determinants of Active Surveillance in Patients With Small Renal Masses. Urology. 2019 Jan; 123:167-173. Nguyen KA, Nolte AC, Alimi O, Hsiang W, Lu AJ, Ghabili K, Syed JS, Suarez-Sarmiento A, Perecman AJ, Shuch B, Leapman MS. PMID: 30059717.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    96. Obesity and renal cell carcinoma risk by histologic subtype: A nested case-control study and meta-analysis. Cancer Epidemiol. 2018 10; 56:31-37. Callahan CL, Hofmann JN, Corley DA, Zhao WK, Shuch B, Chow WH, Purdue MP. PMID: 30029068; PMCID: PMC6151870.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    97. Krebs-cycle-deficient hereditary cancer syndromes are defined by defects in homologous-recombination DNA repair. Nat Genet. 2018 08; 50(8):1086-1092. Sulkowski PL, Sundaram RK, Oeck S, Corso CD, Liu Y, Noorbakhsh S, Niger M, Boeke M, Ueno D, Kalathil AN, Bao X, Li J, Shuch B, Bindra RS, Glazer PM. PMID: 30013182; PMCID: PMC6072579.
      View in: PubMed   Mentions: 101     Fields:    Translation:HumansCells
    98. The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Jun 19; 23(12):3698. Ricketts CJ, De Cubas AA, Fan H, Smith CC, Lang M, Reznik E, Bowlby R, Gibb EA, Akbani R, Beroukhim R, Bottaro DP, Choueiri TK, Gibbs RA, Godwin AK, Haake S, Hakimi AA, Henske EP, Hsieh JJ, Ho TH, Kanchi RS, Krishnan B, Kwiatkowski DJ, Lui W, Merino MJ, Mills GB, Myers J, Nickerson ML, Reuter VE, Schmidt LS, Shelley CS, Shen H, Shuch B, Signoretti S, Srinivasan R, Tamboli P, Thomas G, Vincent BG, Vocke CD, Wheeler DA, Yang L, Kim WY, Robertson AG, Cancer Genome Atlas Research Network, Spellman PT, Rathmell WK, Linehan WM. PMID: 29925010.
      View in: PubMed   Mentions: 115     Fields:    
    99. Genomic Heterogeneity and the Small Renal Mass. Clin Cancer Res. 2018 09 01; 24(17):4137-4144. Ueno D, Xie Z, Boeke M, Syed J, Nguyen KA, McGillivray P, Adeniran A, Humphrey P, Dancik GM, Kluger Y, Liu Z, Kluger H, Shuch B. PMID: 29760223; PMCID: PMC6125159.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    100. Analysis of mutation, selection, and epistasis: an informed approach to cancer clinical trials. Oncotarget. 2018 Apr 27; 9(32):22243-22253. Wilkins JF, Cannataro VL, Shuch B, Townsend JP. PMID: 29854275; PMCID: PMC5976461.
      View in: PubMed   Mentions: 9     Fields:    
    101. Genetic testing for hereditary prostate cancer: Current status and limitations. Cancer. 2018 08 01; 124(15):3105-3117. Zhen JT, Syed J, Nguyen KA, Leapman MS, Agarwal N, Brierley K, Llor X, Hofstatter E, Shuch B. PMID: 29669169.
      View in: PubMed   Mentions: 51     Fields:    Translation:Humans
    102. The Cell Cycle Progression Score: Unclear Role in Renal Cell Carcinoma. Eur Urol. 2018 07; 74(1):128-129. Ueno D, Dancik GM, Shuch B. PMID: 29661484.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    103. The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 04 03; 23(1):313-326.e5. Ricketts CJ, De Cubas AA, Fan H, Smith CC, Lang M, Reznik E, Bowlby R, Gibb EA, Akbani R, Beroukhim R, Bottaro DP, Choueiri TK, Gibbs RA, Godwin AK, Haake S, Hakimi AA, Henske EP, Hsieh JJ, Ho TH, Kanchi RS, Krishnan B, Kwiatkowski DJ, Liu W, Merino MJ, Mills GB, Myers J, Nickerson ML, Reuter VE, Schmidt LS, Shelley CS, Shen H, Shuch B, Signoretti S, Srinivasan R, Tamboli P, Thomas G, Vincent BG, Vocke CD, Wheeler DA, Yang L, Kim WY, Robertson AG, Cancer Genome Atlas Research Network, Spellman PT, Rathmell WK, Linehan WM. PMID: 29617669; PMCID: PMC6075733.
      View in: PubMed   Mentions: 347     Fields:    Translation:Humans
    104. Role of Genetic Testing for Inherited Prostate Cancer Risk: Philadelphia Prostate Cancer Consensus Conference 2017. J Clin Oncol. 2018 02 01; 36(4):414-424. Giri VN, Knudsen KE, Kelly WK, Abida W, Andriole GL, Bangma CH, Bekelman JE, Benson MC, Blanco A, Burnett A, Catalona WJ, Cooney KA, Cooperberg M, Crawford DE, Den RB, Dicker AP, Eggener S, Fleshner N, Freedman ML, Hamdy FC, Hoffman-Censits J, Hurwitz MD, Hyatt C, Isaacs WB, Kane CJ, Kantoff P, Karnes RJ, Karsh LI, Klein EA, Lin DW, Loughlin KR, Lu-Yao G, Malkowicz SB, Mann MJ, Mark JR, McCue PA, Miner MM, Morgan T, Moul JW, Myers RE, Nielsen SM, Obeid E, Pavlovich CP, Peiper SC, Penson DF, Petrylak D, Pettaway CA, Pilarski R, Pinto PA, Poage W, Raj GV, Rebbeck TR, Robson ME, Rosenberg MT, Sandler H, Sartor O, Schaeffer E, Schwartz GF, Shahin MS, Shore ND, Shuch B, Soule HR, Tomlins SA, Trabulsi EJ, Uzzo R, Vander Griend DJ, Walsh PC, Weil CJ, Wender R, Gomella LG. PMID: 29236593; PMCID: PMC6075860.
      View in: PubMed   Mentions: 74     Fields:    Translation:Humans
    105. Survival outcomes for patients with localised upper tract urothelial carcinoma managed with non-definitive treatment. BJU Int. 2018 01; 121(1):124-129. Syed JS, Nguyen KA, Suarez-Sarmiento A, Johnson K, Leapman MS, Raman JD, Shuch B. PMID: 28972702.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    106. Optimizing waiting duration for renal transplants in the setting of renal malignancy: is 2 years too long to wait? Nephrol Dial Transplant. 2017 Oct 01; 32(10):1767-1773. Nguyen KA, Syed JS, Luciano R, Shuch B, Vourganti S. PMID: 28967967; PMCID: PMC5837216.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    107. Ethnic disparities in renal cell carcinoma: An analysis of Hispanic patients in a single-payer healthcare system. Int J Urol. 2017 10; 24(10):765-770. Suarez-Sarmiento A, Yao X, Hofmann JN, Syed JS, Zhao WK, Purdue MP, Chow WH, Corley D, Shuch B. PMID: 28913849; PMCID: PMC6400277.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    108. Advances in the diagnosis of hereditary kidney cancer: Initial results of a multigene panel test. Cancer. 2017 Nov 15; 123(22):4363-4371. Nguyen KA, Syed JS, Espenschied CR, LaDuca H, Bhagat AM, Suarez-Sarmiento A, O'Rourke TK, Brierley KL, Hofstatter EW, Shuch B. PMID: 28787086.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCells
    109. Transforming the Perioperative Treatment Paradigm in Non-Metastatic RCC-A Possible Path Forward. Kidney Cancer. 2017 Jul 26; 1(1):31-40. Harshman LC, Drake CG, Haas NB, Manola J, Puligandla M, Signoretti S, Cella D, Gupta RT, Bhatt R, Van Allen E, Lara P, Choueiri TK, Kapoor A, Heng DYC, Shuch B, Jewett M, George D, Michaelson D, Carducci MA, McDermott D, Allaf M. PMID: 30334002; PMCID: PMC6179104.
      View in: PubMed   Mentions: 6  
    110. Leukocyte telomere length and renal cell carcinoma survival in two studies. Br J Cancer. 2017 Aug 22; 117(5):752-755. Callahan CL, Schwartz K, Ruterbusch JJ, Shuch B, Graubard BI, Lan Q, Cawthon R, Baccarelli AA, Chow WH, Rothman N, Hofmann JN, Purdue MP. PMID: 28742796; PMCID: PMC5572185.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    111. Current Treatment Landscape of Advanced Papillary Renal Cancer. J Clin Oncol. 2017 09 10; 35(26):2981-2983. Shuch B, Hahn AW, Agarwal N. PMID: 28737973.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    112. Recommendations for the Management of Rare Kidney Cancers. Eur Urol. 2017 12; 72(6):974-983. Giles RH, Choueiri TK, Heng DY, Albiges L, Hsieh JJ, Linehan WM, Pal S, Maskens D, Paseman B, Jonasch E, Malouf G, Molina AM, Pickering L, Shuch B, Srinivas S, Srinivasan R, Tannir NM, Bex A. PMID: 28720391.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansCells
    113. Characterization of Clinical Cases of Advanced Papillary Renal Cell Carcinoma via Comprehensive Genomic Profiling. Eur Urol. 2018 01; 73(1):71-78. Pal SK, Ali SM, Yakirevich E, Geynisman DM, Karam JA, Elvin JA, Frampton GM, Huang X, Lin DI, Rosenzweig M, Lipson D, Stephens PJ, Ross JS, Miller VA, Agarwal N, Shuch B, Choueiri TK, Chung JH. PMID: 28592388.
      View in: PubMed   Mentions: 46     Fields:    Translation:HumansCells
    114. Kidney Cancer, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2017 06; 15(6):804-834. Motzer RJ, Jonasch E, Agarwal N, Bhayani S, Bro WP, Chang SS, Choueiri TK, Costello BA, Derweesh IH, Fishman M, Gallagher TH, Gore JL, Hancock SL, Harrison MR, Kim W, Kyriakopoulos C, LaGrange C, Lam ET, Lau C, Michaelson MD, Olencki T, Pierorazio PM, Plimack ER, Redman BG, Shuch B, Somer B, Sonpavde G, Sosman J, Dwyer M, Kumar R. PMID: 28596261.
      View in: PubMed   Mentions: 235     Fields:    Translation:Humans
    115. Adverse pathologic characteristics in the small renal mass: implications for active surveillance. Can J Urol. 2017 Apr; 24(2):8759-8764. Syed JS, Nawaf CB, Rosoff J, Bryson C, Nguyen KA, Suarez-Sarmiento A, Serrano M, Kibel AS, Humphrey P, Shuch B, Adeniran AJ. PMID: 28436365.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    116. Whole-genome analysis of papillary kidney cancer finds significant noncoding alterations. PLoS Genet. 2017 03; 13(3):e1006685. Li S, Shuch BM, Gerstein MB. PMID: 28358873; PMCID: PMC5391127.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCells
    117. End-stage renal disease secondary to renal malignancy: Epidemiologic trends and survival outcomes. Urol Oncol. 2017 08; 35(8):529.e1-529.e7. Nguyen KA, Vourganti S, Syed JS, Luciano R, Campbell SC, Shuch B. PMID: 28363473.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    118. Hereditary Kidney Cancer Syndromes and Surgical Management of the Small Renal Mass. Urol Clin North Am. 2017 May; 44(2):155-167. Nguyen KA, Syed JS, Shuch B. PMID: 28411908.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    119. Distinguishing pediatric and adolescent renal cell carcinoma from other renal malignancies. Pediatr Blood Cancer. 2017 05; 64(5). Syed JS, Nguyen KA, Wu CQ, Cost NG, Siddiqui MM, Hittelman AB, Shuch B. PMID: 27805307.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    120. Ablative Therapies for Early Stage Kidney Cancer and the Evolving Role of the Urologist. Urol Pract. 2017 Mar; 4(2):162-168. Lenis AT, Tan HJ, Halpern JA, Laviana AA, Shuch B, Hu JC. PMID: 37300114.
      View in: PubMed   Mentions:    Fields:    
    121. Up-front Targeted Therapy Prior to Cytoreductive Nephrectomy in Treatment-Naive Patients With Metastatic Renal Cell Carcinoma. JAMA Oncol. 2016 Oct 01; 2(10):1273-1274. Agarwal N, Shuch B, Pal SK. PMID: 27254305.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    122. Management of renal cell carcinoma in young patients and patients with hereditary syndromes. Curr Opin Urol. 2016 09; 26(5):396-404. Leung C, Pan S, Shuch B. PMID: 27387961.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    123. MET Inhibition in Clear Cell Renal Cell Carcinoma. J Cancer. 2016; 7(10):1205-14. Xie Z, Lee YH, Boeke M, Jilaveanu LB, Liu Z, Bottaro DP, Kluger HM, Shuch B. PMID: 27390595; PMCID: PMC4934028.
      View in: PubMed   Mentions: 14  
    124. Racial disparities in renal cell carcinoma: a single-payer healthcare experience. Cancer Med. 2016 08; 5(8):2101-8. Mafolasire A, Yao X, Nawaf C, Suarez-Sarmiento A, Chow WH, Zhao W, Corley D, Hofmann JN, Purdue M, Adeniran AJ, Shuch B. PMID: 27228559; PMCID: PMC4884637.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    125. Multi-kinase inhibitors can associate with heat shock proteins through their NH2-termini by which they suppress chaperone function. Oncotarget. 2016 Mar 15; 7(11):12975-96. Booth L, Shuch B, Albers T, Roberts JL, Tavallai M, Proniuk S, Zukiwski A, Wang D, Chen CS, Bottaro D, Ecroyd H, Lebedyeva IO, Dent P. PMID: 26887051; PMCID: PMC4914336.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansCells
    126. Multilevel Genomics-Based Taxonomy of Renal Cell Carcinoma. Cell Rep. 2016 Mar 15; 14(10):2476-89. Chen F, Zhang Y, Senbabaoglu Y, Ciriello G, Yang L, Reznik E, Shuch B, Micevic G, De Velasco G, Shinbrot E, Noble MS, Lu Y, Covington KR, Xi L, Drummond JA, Muzny D, Kang H, Lee J, Tamboli P, Reuter V, Shelley CS, Kaipparettu BA, Bottaro DP, Godwin AK, Gibbs RA, Getz G, Kucherlapati R, Park PJ, Sander C, Henske EP, Zhou JH, Kwiatkowski DJ, Ho TH, Choueiri TK, Hsieh JJ, Akbani R, Mills GB, Hakimi AA, Wheeler DA, Creighton CJ. PMID: 26947078; PMCID: PMC4794376.
      View in: PubMed   Mentions: 192     Fields:    Translation:HumansCells
    127. Genomic characterization of sarcomatoid transformation in clear cell renal cell carcinoma. Proc Natl Acad Sci U S A. 2016 Feb 23; 113(8):2170-5. Bi M, Zhao S, Said JW, Merino MJ, Adeniran AJ, Xie Z, Nawaf CB, Choi J, Belldegrun AS, Pantuck AJ, Kluger HM, Bilgüvar K, Lifton RP, Shuch B. PMID: 26864202; PMCID: PMC4776463.
      View in: PubMed   Mentions: 57     Fields:    Translation:HumansCells
    128. Hereditary Renal Cell Carcinoma Syndromes: Clinical, Pathologic, and Genetic Features. Am J Surg Pathol. 2015 Dec; 39(12):e1-e18. Adeniran AJ, Shuch B, Humphrey PA. PMID: 26559379.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    129. Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma. N Engl J Med. 2016 Jan 14; 374(2):135-45. Cancer Genome Atlas Research Network, Linehan WM, Spellman PT, Ricketts CJ, Creighton CJ, Fei SS, Davis C, Wheeler DA, Murray BA, Schmidt L, Vocke CD, Peto M, Al Mamun AA, Shinbrot E, Sethi A, Brooks S, Rathmell WK, Brooks AN, Hoadley KA, Robertson AG, Brooks D, Bowlby R, Sadeghi S, Shen H, Weisenberger DJ, Bootwalla M, Baylin SB, Laird PW, Cherniack AD, Saksena G, Haake S, Li J, Liang H, Lu Y, Mills GB, Akbani R, Leiserson MD, Raphael BJ, Anur P, Bottaro D, Albiges L, Barnabas N, Choueiri TK, Czerniak B, Godwin AK, Hakimi AA, Ho TH, Hsieh J, Ittmann M, Kim WY, Krishnan B, Merino MJ, Mills Shaw KR, Reuter VE, Reznik E, Shelley CS, Shuch B, Signoretti S, Srinivasan R, Tamboli P, Thomas G, Tickoo S, Burnett K, Crain D, Gardner J, Lau K, Mallery D, Morris S, Paulauskis JD, Penny RJ, Shelton C, Shelton WT, Sherman M, Thompson E, Yena P, Avedon MT, Bowen J, Gastier-Foster JM, Gerken M, Leraas KM, Lichtenberg TM, Ramirez NC, Santos T, Wise L, Zmuda E, Demchok JA, Felau I, Hutter CM, Sheth M, Sofia HJ, Tarnuzzer R, Wang Z, Yang L, Zenklusen JC, Zhang J, Ayala B, Baboud J, Chudamani S, Liu J, Lolla L, Naresh R, Pihl T, Sun Q, Wan Y, Wu Y, Ally A, Balasundaram M, Balu S, Beroukhim R, Bodenheimer T, Buhay C, Butterfield YS, Carlsen R, Carter SL, Chao H, Chuah E, Clarke A, Covington KR, Dahdouli M, Dewal N, Dhalla N, Doddapaneni HV, Drummond JA, Gabriel SB, Gibbs RA, Guin R, Hale W, Hawes A, Hayes DN, Holt RA, Hoyle AP, Jefferys SR, Jones SJ, Jones CD, Kalra D, Kovar C, Lewis L, Li J, Ma Y, Marra MA, Mayo M, Meng S, Meyerson M, Mieczkowski PA, Moore RA, Morton D, Mose LE, Mungall AJ, Muzny D, Parker JS, Perou CM, Roach J, Schein JE, Schumacher SE, Shi Y, Simons JV, Sipahimalani P, Skelly T, Soloway MG, Sougnez C, Tam A, Tan D, Thiessen N, Veluvolu U, Wang M, Wilkerson MD, Wong T, Wu J, Xi L, Zhou J, Bedford J, Chen F, Fu Y, Gerstein M, Haussler D, Kasaian K, Lai P, Ling S, Radenbaugh A, Van Den Berg D, Weinstein JN, Zhu J, Albert M, Alexopoulou I, Andersen JJ, Auman JT, Bartlett J, Bastacky S, Bergsten J, Blute ML, Boice L, Bollag RJ, Boyd J, Castle E, Chen YB, Cheville JC, Curley E, Davies B, DeVolk A, Dhir R, Dike L, Eckman J, Engel J, Harr J, Hrebinko R, Huang M, Huelsenbeck-Dill L, Iacocca M, Jacobs B, Lobis M, Maranchie JK, McMeekin S, Myers J, Nelson J, Parfitt J, Parwani A, Petrelli N, Rabeno B, Roy S, Salner AL, Slaton J, Stanton M, Thompson RH, Thorne L, Tucker K, Weinberger PM, Winemiller C, Zach LA, Zuna R. PMID: 26536169; PMCID: PMC4775252.
      View in: PubMed   Mentions: 547     Fields:    Translation:HumansCells
    130. MET Expression in Primary and Metastatic Clear Cell Renal Cell Carcinoma: Implications of Correlative Biomarker Assessment to MET Pathway Inhibitors. Biomed Res Int. 2015; 2015:192406. Shuch B, Falbo R, Parisi F, Adeniran A, Kluger Y, Kluger HM, Jilaveanu LB. PMID: 26448928; PMCID: PMC4584049.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    131. The authors respond. Epidemiology. 2015 Jul; 26(4):e49. Hofmann JN, Corley DA, Colt JS, Shuch B, Chow WH, Purdue MP. PMID: 25899997; PMCID: PMC4452404.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    132. Seminoma in Cryptorchid Testis in Prune Belly Syndrome. J Urol. 2015 Sep; 194(3):799-800. Humphrey PA, Shuch B. PMID: 26057338.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    133. Testicular Cancer, Version 2.2015. J Natl Compr Canc Netw. 2015 Jun; 13(6):772-99. Motzer RJ, Jonasch E, Agarwal N, Beard C, Bhayani S, Bolger GB, Chang SS, Choueiri TK, Costello BA, Derweesh IH, Gupta S, Hancock SL, Kim JJ, Kuzel TM, Lam ET, Lau C, Levine EG, Lin DW, Michaelson MD, Olencki T, Pili R, Plimack ER, Rampersaud EN, Redman BG, Ryan CJ, Sheinfeld J, Shuch B, Sircar K, Somer B, Wilder RB, Dwyer M, Kumar R. PMID: 26085393.
      View in: PubMed   Mentions: 47     Fields:    Translation:Humans
    134. Association of urinary bladder paragangliomas with germline mutations in the SDHB and VHL genes. Urol Oncol. 2015 Apr; 33(4):167.e13-20. Martucci VL, Lorenzo ZG, Weintraub M, del Rivero J, Ling A, Merino M, Siddiqui M, Shuch B, Vourganti S, Linehan WM, Agarwal PK, Pacak K. PMID: 25683602; PMCID: PMC4417377.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    135. Kidney cancer, version 3.2015. J Natl Compr Canc Netw. 2015 Feb; 13(2):151-9. Motzer RJ, Jonasch E, Agarwal N, Beard C, Bhayani S, Bolger GB, Chang SS, Choueiri TK, Costello BA, Derweesh IH, Gupta S, Hancock SL, Kim JJ, Kuzel TM, Lam ET, Lau C, Levine EG, Lin DW, Michaelson MD, Olencki T, Pili R, Plimack ER, Rampersaud EN, Redman BG, Ryan CJ, Sheinfeld J, Shuch B, Sircar K, Somer B, Wilder RB, Dwyer M, Kumar R, National comprehensive cancer network. PMID: 25691606.
      View in: PubMed   Mentions: 81     Fields:    Translation:Humans
    136. Chronic kidney disease and risk of renal cell carcinoma: differences by race. Epidemiology. 2015 Jan; 26(1):59-67. Hofmann JN, Corley DA, Zhao WK, Colt JS, Shuch B, Chow WH, Purdue MP. PMID: 25393631; PMCID: PMC4422505.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    137. PAX-8 expression in renal tumours and distant sites: a useful marker of primary and metastatic renal cell carcinoma? J Clin Pathol. 2015 Jan; 68(1):12-7. Barr ML, Jilaveanu LB, Camp RL, Adeniran AJ, Kluger HM, Shuch B. PMID: 25315900; PMCID: PMC4429054.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    138. The somatic genomic landscape of chromophobe renal cell carcinoma. Cancer Cell. 2014 Sep 08; 26(3):319-330. Davis CF, Ricketts CJ, Wang M, Yang L, Cherniack AD, Shen H, Buhay C, Kang H, Kim SC, Fahey CC, Hacker KE, Bhanot G, Gordenin DA, Chu A, Gunaratne PH, Biehl M, Seth S, Kaipparettu BA, Bristow CA, Donehower LA, Wallen EM, Smith AB, Tickoo SK, Tamboli P, Reuter V, Schmidt LS, Hsieh JJ, Choueiri TK, Hakimi AA, The Cancer Genome Atlas Research Network, Chin L, Meyerson M, Kucherlapati R, Park WY, Robertson AG, Laird PW, Henske EP, Kwiatkowski DJ, Park PJ, Morgan M, Shuch B, Muzny D, Wheeler DA, Linehan WM, Gibbs RA, Rathmell WK, Creighton CJ. PMID: 25155756; PMCID: PMC4160352.
      View in: PubMed   Mentions: 385     Fields:    Translation:HumansCells
    139. Vascular Endothelial Growth Factor Receptor-Targeted Therapy in Succinate Dehydrogenase C Kidney Cancer. J Clin Oncol. 2016 Mar 20; 34(9):e76-9. Shuch B, Agochukwu N, Ricketts CJ, Vocke CD, Gautam R, Merino M, Linehan WM, Srinivasan R. PMID: 25024072; PMCID: PMC7518104.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    140. Understanding pathologic variants of renal cell carcinoma: distilling therapeutic opportunities from biologic complexity. Eur Urol. 2015 Jan; 67(1):85-97. Shuch B, Amin A, Armstrong AJ, Eble JN, Ficarra V, Lopez-Beltran A, Martignoni G, Rini BI, Kutikov A. PMID: 24857407.
      View in: PubMed   Mentions: 255     Fields:    Translation:Humans
    141. Clinical management of renal cell carcinoma with venous tumor thrombus. World J Urol. 2014 Jun; 32(3):581-9. Agochukwu N, Shuch B. PMID: 24752606.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    142. The genetic basis of pheochromocytoma and paraganglioma: implications for management. Urology. 2014 Jun; 83(6):1225-32. Shuch B, Ricketts CJ, Metwalli AR, Pacak K, Linehan WM. PMID: 24642075; PMCID: PMC4572836.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    143. PD-L1 Expression in Clear Cell Renal Cell Carcinoma: An Analysis of Nephrectomy and Sites of Metastases. J Cancer. 2014; 5(3):166-72. Jilaveanu LB, Shuch B, Zito CR, Parisi F, Barr M, Kluger Y, Chen L, Kluger HM. PMID: 24563671; PMCID: PMC3931264.
      View in: PubMed   Mentions: 71  
    144. A nested case-control study of leukocyte mitochondrial DNA copy number and renal cell carcinoma in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. Carcinogenesis. 2014 May; 35(5):1028-31. Hofmann JN, Hosgood HD, Liu CS, Chow WH, Shuch B, Cheng WL, Lin TT, Moore LE, Lan Q, Rothman N, Purdue MP. PMID: 24398668; PMCID: PMC4004202.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansCells
    145. Defining early-onset kidney cancer: implications for germline and somatic mutation testing and clinical management. J Clin Oncol. 2014 Feb 10; 32(5):431-7. Shuch B, Vourganti S, Ricketts CJ, Middleton L, Peterson J, Merino MJ, Metwalli AR, Srinivasan R, Linehan WM. PMID: 24378414; PMCID: PMC3912328.
      View in: PubMed   Mentions: 64     Fields:    Translation:Humans
    146. MRI characterization of the dynamic effects of 5α-reductase inhibitors on prostate zonal volumes. Can J Urol. 2013 Dec; 20(6):7002-7. Truong H, Logan J, Turkbey B, Siddiqui MM, Rais-Bahrami S, Hoang AN, Pusateri C, Shuch B, Walton-Diaz A, Vourganti S, Nix J, Stamatakis L, Harris C, Chua C, Choyke PL, Wood BJ, Pinto PA. PMID: 24331340; PMCID: PMC7589483.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    147. Adverse health outcomes associated with surgical management of the small renal mass. J Urol. 2014 Feb; 191(2):301-8. Shuch B, Hanley JM, Lai JC, Vourganti S, Setodji CM, Dick AW, Chow WH, Saigal CS, Urologic Diseases in America Project. PMID: 24012580.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    148. Metabolic reprogramming for producing energy and reducing power in fumarate hydratase null cells from hereditary leiomyomatosis renal cell carcinoma. PLoS One. 2013; 8(8):e72179. Yang Y, Lane AN, Ricketts CJ, Sourbier C, Wei MH, Shuch B, Pike L, Wu M, Rouault TA, Boros LG, Fan TW, Linehan WM. PMID: 23967283; PMCID: PMC3744468.
      View in: PubMed   Mentions: 66     Fields:    Translation:HumansCells
    149. Accuracy of multiparametric magnetic resonance imaging in confirming eligibility for active surveillance for men with prostate cancer. Cancer. 2013 Sep 15; 119(18):3359-66. Stamatakis L, Siddiqui MM, Nix JW, Logan J, Rais-Bahrami S, Walton-Diaz A, Hoang AN, Vourganti S, Truong H, Shuch B, Parnes HL, Turkbey B, Choyke PL, Wood BJ, Simon RM, Pinto PA. PMID: 23821585; PMCID: PMC6663489.
      View in: PubMed   Mentions: 91     Fields:    Translation:Humans
    150. Magnetic resonance imaging/ultrasound-fusion biopsy significantly upgrades prostate cancer versus systematic 12-core transrectal ultrasound biopsy. Eur Urol. 2013 Nov; 64(5):713-719. Siddiqui MM, Rais-Bahrami S, Truong H, Stamatakis L, Vourganti S, Nix J, Hoang AN, Walton-Diaz A, Shuch B, Weintraub M, Kruecker J, Amalou H, Turkbey B, Merino MJ, Choyke PL, Wood BJ, Pinto PA. PMID: 23787357; PMCID: PMC6301057.
      View in: PubMed   Mentions: 190     Fields:    Translation:HumansCTClinical Trials
    151. Germline PTEN mutation Cowden syndrome: an underappreciated form of hereditary kidney cancer. J Urol. 2013 Dec; 190(6):1990-8. Shuch B, Ricketts CJ, Vocke CD, Komiya T, Middelton LA, Kauffman EC, Merino MJ, Metwalli AR, Dennis P, Linehan WM. PMID: 23764071; PMCID: PMC4193347.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    152. Aerobic glycolysis: a novel target in kidney cancer. Expert Rev Anticancer Ther. 2013 Jun; 13(6):711-9. Shuch B, Linehan WM, Srinivasan R. PMID: 23773105; PMCID: PMC4165485.
      View in: PubMed   Mentions: 45     Fields:    Translation:HumansAnimalsCells
    153. Overall survival advantage with partial nephrectomy: a bias of observational data? Cancer. 2013 Aug 15; 119(16):2981-9. Shuch B, Hanley J, Lai J, Vourganti S, Kim SP, Setodji CM, Dick AW, Chow WH, Saigal C, Urologic Diseases in America Project. PMID: 23674264.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    154. Low Grade Micropapillary Urothelial Carcinoma, Does It Exist? - Analysis of Management and Outcomes from the Surveillance, Epidemiology and End Results (SEER) Database. J Cancer. 2013; 4(4):336-42. Vourganti S, Harbin A, Singer EA, Shuch B, Metwalli AR, Agarwal PK. PMID: 23678370; PMCID: PMC3654490.
      View in: PubMed   Mentions: 12  
    155. A prospective study of leukocyte telomere length and risk of renal cell carcinoma. Cancer Epidemiol Biomarkers Prev. 2013 May; 22(5):997-1000. Hofmann JN, Lan Q, Cawthon R, Hosgood HD, Shuch B, Moore LE, Rothman N, Chow WH, Purdue MP. PMID: 23513041; PMCID: PMC3655903.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    156. Pathologic validation of renal cell carcinoma histology in the Surveillance, Epidemiology, and End Results program. Urol Oncol. 2014 Jan; 32(1):23.e9-13. Shuch B, Hofmann JN, Merino MJ, Nix JW, Vourganti S, Linehan WM, Schwartz K, Ruterbusch JJ, Colt JS, Purdue MP, Chow WH. PMID: 23453468; PMCID: PMC4435970.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    157. An investigation of risk factors for renal cell carcinoma by histologic subtype in two case-control studies. Int J Cancer. 2013 Jun 01; 132(11):2640-7. Purdue MP, Moore LE, Merino MJ, Boffetta P, Colt JS, Schwartz KL, Bencko V, Davis FG, Graubard BI, Janout V, Ruterbusch JJ, Beebe-Dimmer J, Cote ML, Shuch B, Mates D, Hofmann JN, Foretova L, Rothman N, Szeszenia-Dabrowska N, Matveev V, Wacholder S, Zaridze D, Linehan WM, Brennan P, Chow WH. PMID: 23150424; PMCID: PMC3717609.
      View in: PubMed   Mentions: 36     Fields:    Translation:Humans
    158. The association between chronic renal failure and renal cell carcinoma may differ between black and white Americans. Cancer Causes Control. 2013 Jan; 24(1):167-74. Hofmann JN, Schwartz K, Chow WH, Ruterbusch JJ, Shuch BM, Karami S, Rothman N, Wacholder S, Graubard BI, Colt JS, Purdue MP. PMID: 23179659; PMCID: PMC3531044.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    159. Racial disparity in renal cell carcinoma patient survival according to demographic and clinical characteristics. Cancer. 2013 Jan 15; 119(2):388-94. Chow WH, Shuch B, Linehan WM, Devesa SS. PMID: 23147245; PMCID: PMC3538913.
      View in: PubMed   Mentions: 45     Fields:    Translation:Humans
    160. Succinate dehydrogenase kidney cancer: an aggressive example of the Warburg effect in cancer. J Urol. 2012 Dec; 188(6):2063-71. Ricketts CJ, Shuch B, Vocke CD, Metwalli AR, Bratslavsky G, Middelton L, Yang Y, Wei MH, Pautler SE, Peterson J, Stolle CA, Zbar B, Merino MJ, Schmidt LS, Pinto PA, Srinivasan R, Pacak K, Linehan WM. PMID: 23083876; PMCID: PMC3856891.
      View in: PubMed   Mentions: 106     Fields:    Translation:Humans
    161. Adrenal nodular hyperplasia in hereditary leiomyomatosis and renal cell cancer. J Urol. 2013 Feb; 189(2):430-5. Shuch B, Ricketts CJ, Vocke CD, Valera VA, Chen CC, Gautam R, Gupta GN, Gomez Macias GS, Merino MJ, Bratslavsky G, Linehan WM. PMID: 22982371; PMCID: PMC4435969.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    162. Kidney cancer: Is incomplete renal ablation linked to tumour progression? Nat Rev Urol. 2012 Oct; 9(10):547-8. Shuch B, Linehan WM. PMID: 22926423.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    163. Targeting the mTOR pathway in Chromophobe Kidney Cancer. J Cancer. 2012; 3:152-7. Shuch B, Vourganti S, Friend JC, Zehngebot LM, Linehan WM, Srinivasan R. PMID: 22481981; PMCID: PMC3319981.
      View in: PubMed   Mentions: 7  
    164. The surgical approach to multifocal renal cancers: hereditary syndromes, ipsilateral multifocality, and bilateral tumors. Urol Clin North Am. 2012 May; 39(2):133-48, v. Shuch B, Singer EA, Bratslavsky G. PMID: 22487757.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    165. Sarcomatoid renal cell carcinoma: a comprehensive review of the biology and current treatment strategies. Oncologist. 2012; 17(1):46-54. Shuch B, Bratslavsky G, Linehan WM, Srinivasan R. PMID: 22234634; PMCID: PMC3267822.
      View in: PubMed   Mentions: 82     Fields:    Translation:Humans
    166. Impact of pathological tumour characteristics in patients with sarcomatoid renal cell carcinoma. BJU Int. 2012 Jun; 109(11):1600-6. Shuch B, Bratslavsky G, Shih J, Vourganti S, Finley D, Castor B, Treat E, Linehan WM, Pantuck AJ, Said JW, Belldegrun AS. PMID: 22221668; PMCID: PMC4676716.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    167. Surgical management of large renal tumors. Expert Rev Anticancer Ther. 2011 Dec; 11(12):1889-900. Vourganti S, Shuch B, Bratslavsky G. PMID: 22117156.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    168. The chromophobe tumor grading system is the preferred grading scheme for chromophobe renal cell carcinoma. J Urol. 2011 Dec; 186(6):2168-74. Finley DS, Shuch B, Said JW, Galliano G, Jeffries RA, Afifi AA, Castor B, Magyar C, Sadaat A, Kabbinavar FF, Belldegrun AS, Pantuck AJ. PMID: 22014797.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    169. Repeat partial nephrectomy: surgical, functional and oncological outcomes. Curr Opin Urol. 2011 Sep; 21(5):368-75. Shuch B, Linehan WM, Bratslavsky G. PMID: 21788903; PMCID: PMC3173810.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    170. Prospective study comparing two techniques of renal clamping in laparoscopic partial nephrectomy: impact on perioperative parameters. J Endourol. 2012 May; 26(5):509-14. Imbeault A, Pouliot F, Finley DS, Shuch B, Dujardin T. PMID: 21823983.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    171. Multivariate analysis of the factors involved in loss of renal differential function after laparoscopic partial nephrectomy: a role for warm ischemia time. Can Urol Assoc J. 2011 Apr; 5(2):89-95. Pouliot F, Pantuck A, Imbeault A, Shuch B, Calimlim B, Audet JF, Finley DS, Dujardin T. PMID: 21470531; PMCID: PMC3104439.
      View in: PubMed   Mentions: 11  
    172. Editorial comment. J Urol. 2011 May; 185(5):1589-90; author reply 1590. Shuch B, Pacak K, Linehan WM, Bratslavsky G. PMID: 21419442; PMCID: PMC4731868.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    173. Cardiopulmonary bypass and renal cell carcinoma with level IV tumour thrombus: can deep hypothermic circulatory arrest limit perioperative mortality? BJU Int. 2011 Mar; 107(5):724-728. Shuch B, Crispen PL, Leibovich BC, LaRochelle JC, Pouliot F, Pantuck AJ, Liu W, Crepel M, Schuckman A, Rigaud J, Bouchot O, Patard JJ, Skinner D, Belldegrun AS, Blute ML. PMID: 20626391.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    174. Ultrasound-based combination therapy: potential in urologic cancer. Expert Rev Anticancer Ther. 2011 Jan; 11(1):107-13. Finley DS, Pouliot F, Shuch B, Chin A, Pantuck A, Dekernion JB, Belldegrun AS. PMID: 21166515.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    175. Quality of pathological reporting for renal cell cancer: implications for systemic therapy, prognostication and surveillance. BJU Int. 2011 Aug; 108(3):343-8. Shuch B, Pantuck AJ, Pouliot F, Finley DS, Said JW, Belldegrun AS, Saigal C. PMID: 21087450.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    176. Immunological therapy in urological malignancy: novel combination strategies. Int J Urol. 2011 Feb; 18(2):94-101. Finley DS, Pouliot F, Chin AI, Shuch B, Pantuck AJ, Belldegrun AS, Dekernion JB. PMID: 21073543.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    177. Pathological, immunohistochemical and cytogenetic features of papillary renal cell carcinoma with clear cell features. J Urol. 2011 Jan; 185(1):30-5. Klatte T, Said JW, Seligson DB, Rao PN, de Martino M, Shuch B, Zomorodian N, Kabbinavar FF, Belldegrun AS, Pantuck AJ. PMID: 21074210.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    178. Chromosome 9p deletions identify an aggressive phenotype of clear cell renal cell carcinoma. Cancer. 2010 Oct 15; 116(20):4696-702. La Rochelle J, Klatte T, Dastane A, Rao N, Seligson D, Said J, Shuch B, Zomorodian N, Kabbinavar F, Belldegrun A, Pantuck AJ. PMID: 20629029.
      View in: PubMed   Mentions: 35     Fields:    Translation:HumansCells
    179. Contemporary management of renal tumors with venous tumor thrombus. J Urol. 2010 Sep; 184(3):833-41; quiz 1235. Pouliot F, Shuch B, Larochelle JC, Pantuck A, Belldegrun AS. PMID: 20643450.
      View in: PubMed   Mentions: 55     Fields:    Translation:HumansCells
    180. The role of fluorescence in situ hybridization assay for surveillance of non-muscle invasive bladder cancer. Can J Urol. 2010 Apr; 17(2):5077-81. Karnwal A, Venegas R, Shuch B, Bassett J, Rajfer J, Reznichek R. PMID: 20398445.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansPHPublic Health
    181. Histologic evaluation of metastases in renal cell carcinoma with sarcomatoid transformation and its implications for systemic therapy. Cancer. 2010 Feb 01; 116(3):616-24. Shuch B, Said J, LaRochelle JC, Zhou Y, Li G, Klatte T, Pouliot F, Kabbinavar FF, Belldegrun AS, Pantuck AJ. PMID: 19998348; PMCID: PMC3162346.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCells
    182. Cytoreductive nephrectomy for kidney cancer with sarcomatoid histology--is up-front resection indicated and, if not, is it avoidable? J Urol. 2009 Nov; 182(5):2164-71. Shuch B, Said J, La Rochelle JC, Zhou Y, Li G, Klatte T, Kabbinaavar FF, Pantuck AJ, Belldegrun AS. PMID: 19758641; PMCID: PMC3175230.
      View in: PubMed   Mentions: 55     Fields:    Translation:Humans
    183. CA9 gene: single nucleotide polymorphism predicts metastatic renal cell carcinoma prognosis. J Urol. 2009 Aug; 182(2):728-34. de Martino M, Klatte T, Seligson DB, LaRochelle J, Shuch B, Caliliw R, Li Z, Kabbinavar FF, Pantuck AJ, Belldegrun AS. PMID: 19539328.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    184. Functional and oncological outcomes of partial nephrectomy of solitary kidneys. J Urol. 2009 May; 181(5):2037-42; discussion 2043. La Rochelle J, Shuch B, Riggs S, Liang LJ, Saadat A, Kabbinavar F, Pantuck A, Belldegrun A. PMID: 19298974.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    185. Molecular signatures of localized clear cell renal cell carcinoma to predict disease-free survival after nephrectomy. Cancer Epidemiol Biomarkers Prev. 2009 Mar; 18(3):894-900. Klatte T, Seligson DB, LaRochelle J, Shuch B, Said JW, Riggs SB, Zomorodian N, Kabbinavar FF, Pantuck AJ, Belldegrun AS. PMID: 19240241.
      View in: PubMed   Mentions: 61     Fields:    Translation:Humans
    186. Presence of tumor necrosis is not a significant predictor of survival in clear cell renal cell carcinoma: higher prognostic accuracy of extent based rather than presence/absence classification. J Urol. 2009 Apr; 181(4):1558-64; discussion 1563-4. Klatte T, Said JW, de Martino M, Larochelle J, Shuch B, Rao JY, Thomas GV, Kabbinavar FF, Belldegrun AS, Pantuck AJ. PMID: 19230920.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    187. Cytogenetic and molecular tumor profiling for type 1 and type 2 papillary renal cell carcinoma. Clin Cancer Res. 2009 Feb 15; 15(4):1162-9. Klatte T, Pantuck AJ, Said JW, Seligson DB, Rao NP, LaRochelle JC, Shuch B, Zisman A, Kabbinavar FF, Belldegrun AS. PMID: 19228721.
      View in: PubMed   Mentions: 66     Fields:    Translation:Humans
    188. Cytogenetic profile predicts prognosis of patients with clear cell renal cell carcinoma. J Clin Oncol. 2009 Feb 10; 27(5):746-53. Klatte T, Rao PN, de Martino M, LaRochelle J, Shuch B, Zomorodian N, Said J, Kabbinavar FF, Belldegrun AS, Pantuck AJ. PMID: 19124809.
      View in: PubMed   Mentions: 85     Fields:    Translation:HumansCells
    189. Best of the 2009 AUA Annual Meeting: Highlights from the 2009 Annual Meeting of the American Urological Association, April 25-30, 2009, Chicago, IL. Rev Urol. 2009; 11(2):82-107. Brawer MK, Loeb S, Partin AW, Yoshimura N, Chancellor MB, Roehrborn CG, Assimos DG, Nickel JC, Shuch B, Pouliot F, Belldegrun AS, Shapiro E. PMID: 19680529; PMCID: PMC2725309.
      View in: PubMed   Mentions:
    190. Intraoperative thrombus embolization during nephrectomy and tumor thrombectomy: critical analysis of the University of California-Los Angeles experience. J Urol. 2009 Feb; 181(2):492-8; discussion 498-9. Shuch B, Larochelle JC, Onyia T, Vallera C, Margulis D, Pantuck AJ, Smith RB, Belldegrun AS. PMID: 19110280.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCells
    191. Cancer-specific survival outcomes among patients treated during the cytokine era of kidney cancer (1989-2005): a benchmark for emerging targeted cancer therapies. Cancer. 2008 Nov 01; 113(9):2457-63. Belldegrun AS, Klatte T, Shuch B, LaRochelle JC, Miller DC, Said JW, Riggs SB, Zomorodian N, Kabbinavar FF, Dekernion JB, Pantuck AJ. PMID: 18823034.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    192. Brain metastasis from renal cell carcinoma: presentation, recurrence, and survival. Cancer. 2008 Oct 01; 113(7):1641-8. Shuch B, La Rochelle JC, Klatte T, Riggs SB, Liu W, Kabbinavar FF, Pantuck AJ, Belldegrun AS. PMID: 18671240.
      View in: PubMed   Mentions: 55     Fields:    Translation:Humans
    193. Performance status and cytoreductive nephrectomy: redefining management in patients with poor performance. Cancer. 2008 Sep 15; 113(6):1324-31. Shuch B, La Rochelle JC, Wu J, Klatte T, Riggs SB, Kabbinavar F, Belldegrun AS, Pantuck AJ. PMID: 18661529.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCTClinical Trials
    194. The staging of renal cell carcinoma. Curr Opin Urol. 2008 Sep; 18(5):455-61. Shuch B, La Rochelle JC, Pantuck AJ, Belldegrun AS. PMID: 18670267.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    195. Carbonic anhydrase IX and renal cell carcinoma: prognosis, response to systemic therapy, and future vaccine strategies. BJU Int. 2008 Jun; 101 Suppl 4:25-30. Shuch B, Li Z, Belldegrun AS. PMID: 18430119.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    196. Re: efficacy of sunitinib and sorafenib in metastatic papillary and chromophobe renal cell carcinoma. Eur Urol. 2008 May; 53(5):1085-6. Shuch B, Belldegrun A. PMID: 18485320.
      View in: PubMed   Mentions: 2     Fields:    
    197. Neoadjuvant targeted therapy and advanced kidney cancer: observations and implications for a new treatment paradigm. BJU Int. 2008 Sep; 102(6):692-6. Shuch B, Riggs SB, LaRochelle JC, Kabbinavar FF, Avakian R, Pantuck AJ, Patard JJ, Belldegrun AS. PMID: 18410444.
      View in: PubMed   Mentions: 56     Fields:    Translation:Humans
    198. Surveillance for renal cell carcinoma: why and how? When and how often? Urol Oncol. 2008 Sep-Oct; 26(5):550-4. Klatte T, Lam JS, Shuch B, Belldegrun AS, Pantuck AJ. PMID: 18774472.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    199. Prognostic factors for renal cell carcinoma with tumor thrombus extension. J Urol. 2007 Oct; 178(4 Pt 1):1189-95; discussion 1195. Klatte T, Pantuck AJ, Riggs SB, Kleid MD, Shuch B, Zomorodian N, Kabbinavar FF, Belldegrun AS. PMID: 17698087.
      View in: PubMed   Mentions: 42     Fields:    Translation:HumansCells
    200. Prognostic factors in renal cell carcinoma. Semin Oncol. 2006 Oct; 33(5):563-75. Shuch BM, Lam JS, Belldegrun AS, Figlin RA. PMID: 17045085.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    201. Open partial nephrectomy for the treatment of renal cell carcinoma. Curr Urol Rep. 2006 Jan; 7(1):31-8. Shuch B, Lam JS, Belldegrun AS. PMID: 16480666.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    202. Serum levels of shed Her2/neu protein in men with prostate cancer correlate with disease progression. J Urol. 2005 Dec; 174(6):2174-7. Osman I, Mikhail M, Shuch B, Clute M, Cheli CD, Ghani F, Thiel RP, Taneja SS. PMID: 16280758.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    203. Racial disparity of epidermal growth factor receptor expression in prostate cancer. J Clin Oncol. 2004 Dec 01; 22(23):4725-9. Shuch B, Mikhail M, Satagopan J, Lee P, Yee H, Chang C, Cordon-Cardo C, Taneja SS, Osman I. PMID: 15570072.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    Brian's Networks
    Concepts (502)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (55)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCLA Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version UCSF-v3.1.0-9-g3adcefa5 on PROFILES-PWEB03. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California